Back to top
more

Doximity (DOCS)

(Delayed Data from NYSE)

$58.30 USD

58.30
2,449,519

+0.97 (1.69%)

Updated Aug 4, 2025 04:00 PM ET

After-Market: $58.29 -0.01 (-0.02%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value A Growth B Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 29% (71 out of 246)

Industry: Medical Info Systems

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Urmimala Biswas headshot

3 Medical Services Industry Stocks to Buy as AI Fuels Growth

by Urmimala Biswas

The Zacks Medical - Services industry is undergoing a transformation on massive artificial intelligence adoption. COR, DOCS and MD are set to gain the most. Healthcare staffing shortages are leading to an increase in labor wages.

Zacks Equity Research

The Zacks Analyst Blog Doximity, Arc Resources and Stifel Financial

by Zacks Equity Research

Doximity, Arc Resources and Stifel Financial are included in this Analyst Blog.

John Blank headshot

A Real Alternative to U.S. Stocks: Global Week Ahead

by John Blank

Move over, TINA ("There Is No Alternative"); investors are considering TIARA: "There Is A Real Alternative" to U.S. stocks.

Zacks Equity Research

Doximity (DOCS) Beats Stock Market Upswing: What Investors Need to Know

by Zacks Equity Research

The latest trading day saw Doximity (DOCS) settling at $62.99, representing a +0.35% change from its previous close.

Sanghamitra Saha headshot

Buy These 5 Top-Ranked Stocks to Play Likely Earnings Beat

by Sanghamitra Saha

Top-ranked stocks Doximity (DOCS), Life Time Group Holdings (LTH), Adtalem Global Education (ATGE), BioMarin Pharmaceutical (BMRN) and Iridium Communications (IRDM) are likely to beat on the bottom line in their upcoming releases.

Zacks Equity Research

Pediatrix Medical Stock Rallies 37.7% in 6 Months: More Room to Run?

by Zacks Equity Research

MD is expected to benefit from rising patient volumes, a favorable payer mix and streamlining initiatives.

Nalak Das headshot

Buy 5 High-Flying Health & Fitness Stocks Year to Date With More Upside

by Nalak Das

Five Health & Fitness stocks have strong growth potential for 2025. These are: GRMN, SFM, DOCS, LTH, VFC.

Zacks Equity Research

Brookdale Expands Real Estate Portfolio With Strategic Acquisitions

by Zacks Equity Research

BKD expands its real estate footprint with the closure of two acquisitions.

Zacks Equity Research

Is Doximity (DOCS) a Solid Growth Stock? 3 Reasons to Think "Yes"

by Zacks Equity Research

Doximity (DOCS) possesses solid growth attributes, which could help it handily outperform the market.

Zacks Equity Research

Doximity and Krispy Kreme have been highlighted as Zacks Bull and Bear of the Day

by Zacks Equity Research

Doximity and Krispy Kreme are part of the Zacks Bull and Bear of the Day article.

Andrew Rocco headshot

Bull of the Day: Doximity (DOCS)

by Andrew Rocco

Doximity's robust growth, consistent EPS beats, and strategic positioning within the rapidly digitizing healthcare sector make it a compelling investment.

Sanghamitra Saha headshot

5 Top-Ranked Stocks Poised for an Earnings Beat

by Sanghamitra Saha

Top-ranked stocks Tenet Healthcare (THC), Fortinet (FTNT), Lyft (LYFT), Garmin (GRMN) and Doximity (DOCS) are likely to beat on the bottom line in their upcoming releases.

Zacks Equity Research

Is First Trust Small Cap Core AlphaDEX ETF (FYX) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for FYX

Zacks Equity Research

Are Medical Stocks Lagging ANI Pharmaceuticals (ANIP) This Year?

by Zacks Equity Research

Here is how ANI Pharmaceuticals (ANIP) and Doximity (DOCS) have performed compared to their sector so far this year.

Zacks Equity Research

Doximity (DOCS) is an Incredible Growth Stock: 3 Reasons Why

by Zacks Equity Research

Doximity (DOCS) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Zacks Equity Research

Why Doximity (DOCS) Might be Well Poised for a Surge

by Zacks Equity Research

Doximity (DOCS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Zacks Equity Research

Doximity (DOCS) is a Great Momentum Stock: Should You Buy?

by Zacks Equity Research

Does Doximity (DOCS) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks Equity Research

Doximity (DOCS) Q3 Earnings and Revenues Top Estimates

by Zacks Equity Research

Doximity (DOCS) delivered earnings and revenue surprises of 36.36% and 10.60%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Is First Trust Health Care AlphaDEX ETF (FXH) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for FXH

Zacks Equity Research

Revvity (RVTY) Surpasses Q4 Earnings Estimates

by Zacks Equity Research

Revvity (RVTY) delivered earnings and revenue surprises of 4.41% and 0.10%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Doximity (DOCS) Gains As Market Dips: What You Should Know

by Zacks Equity Research

Doximity (DOCS) closed the most recent trading day at $57.67, moving +0.95% from the previous trading session.

Zacks Equity Research

Should You Invest in the First Trust Health Care AlphaDEX ETF (FXH)?

by Zacks Equity Research

Sector ETF report for FXH

Zacks Equity Research

The Zacks Analyst Blog Doximity, Omnicell, Embecta, Cencora and EDOC

by Zacks Equity Research

Doximity, Omnicell, Embecta, Cencora and EDOC are included in this Analyst Blog.

Urmimala Biswas headshot

4 MedTech Stocks Poised to Thrive Under Second Trump Presidency

by Urmimala Biswas

Four MedTech stocks that are set to benefit from Trump 2.0 are DOCS, OMCL, EMBC and COR.

Zacks Equity Research

Teladoc Partners With Amazon to Expand Chronic Care Program Reach

by Zacks Equity Research

TDOC collaborates with Amazon to enhance its reach for chronic condition management programs.